Business
Admission today to trading on Euronext Growth
Admission today to trading on Euronext Growth.
About this update from Immupharma Plc
[{"type":"text","content":"\n \nRNS Number : 2964X Immupharma PLC 19 December 2019 \n\nRNS | 19 December 2019\n \nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \nAdmission today to trading on Euronext Growth Brussels\nImmuPharma PLC (LSE:IMM span class=\"bh\">Euronext Growth: ALIMM), a specialist drug discovery and development company, is pleased to announce that, this morning at approximately 09.00am (GMT), ImmuPharma will commence trading on Euronext Growth Brussels (\"Euronext\") under ticker 'ALIMM'. \nThis new listing does not affect the trading of ImmuPharma's shares on AIM, nor is there any intention from the Company to raise additional funds from either AIM or Euronext.\nThe dual listing on Euronext Growth Brussels aims to further increase the visibility of ImmuPharma's shares with European investors, aligned with the investment thesis for ImmuPharma and specifically Lupuzor™ being repositioned, following the Company's recent deal with US Avion Pharmaceuticals, who are funding an international Phase III trial for ImmuPharma's lead programme, Lupuzor™. ImmuPharma looks forward to providing further progress updates on the Phase III program with Avion, as well as entering into additional partnerships outside of the US.\nThis announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014. (\"MAR\")\n\n\n\n \nFor further information please contact:\n \n\n\n\nImmuPharma PLC (www.immupharma.com)\nTim McCarthy, Chairman\n\n\n+ 44 (0) 207 152 4080\n\n\n\n\nDimitri Dimitriou, Chief Executive Officer\n\n\n\n\n\n\n\nLisa Baderoon, Head of Investor Relations\n\n\n+ 44 (0) 7721 413496\n \n\n\n\n\n \nSPARK Advisory Partners Limited (NOMAD)\nNeil Baldwin\nVassil Kirtchev\n \nStanford Capital Partners (Joint Broker) \nPatrick Claridge, John Howes\n \nSI Capital (Joint Broker)\nNick Emerson\n \n\n\n \n+44 (0) 203 368 8974\n \n \n \n+44 (0) 203 815 8880\n \n \n+44 (0) 1483 413500\n \n \n\n\n\n\n\n\n\n4Reliance (Euronext Growth Listing Sponsor)\nJean-Charles Snoy\n \nDegroof Petercam (Liquidity Provider)\nErik De Clippel\n \nBackstage Communication\nOlivier Duquaine\nJean-Louis Dubrule\n\n\n+32 (0) 2 747 02 60\n \n \n \n+32 (0) 477 504 784\n+32 (0) 497 50 84 03\n \n\n\n\n\n\n\n+32 (0) 2 747 02 60\n&nbs...